🔎 Trials Near Me

Dachaigh › Osteosarcoma › Massachusetts

Sgrùdaidhean clionaigeach Osteosarcoma ann an Massachusetts

Tha 9 sgrùdaidhean airson Osteosarcoma a’ lorg phàirtichean aig làraichean ann an Massachusetts.

Bailtean ann an Massachusetts

Teacsa sgrùdaidh oifigeil (Beurla)

Trastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell Tumor

  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 2
Aoisean 12 gu 39 · Gach gnè · Air ùrachadh 29 Sult 2026 · NCT04616560

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

  • Massachusetts General Hospital Cancer Center, Boston
  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 3
Suas gu aois 50 · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT05235165

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 1/2
12 Months – 30 Years · Gach gnè · Air ùrachadh 25 Lùna 2026 · NCT04851119

SPEARHEAD-3 Pediatric Study

  • Dana Farber Cancer Institute, Boston
A’ fastadhÌre 1/2
Aoisean 2 gu 21 · Gach gnè · Air ùrachadh 11 Lùna 2026 · NCT05642455

NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)

  • Dana Farber Cancer Institute, Boston
A’ fastadhÌre 1/2
Suas gu aois 30 · Gach gnè · Air ùrachadh 3 Lùna 2026 · NCT06239272

Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment

  • Dana-Farber Cancer Institute, Boston
A’ fastadhSgrùdadh amharc
Gach aois · Gach gnè · Air ùrachadh 18 Cèit 2026 · NCT01790152

Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)

  • Dana Farber Cancer Institute, Boston
A’ fastadhÌre 1/2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 1 Cèit 2026 · NCT07357519

Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study

  • Dana-Farber Cancer Institute, Boston
A’ fastadhÌre 2
Aoisean 12 agus nas sine · Gach gnè · Air ùrachadh 17 Gibl 2026 · NCT05019703

Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas

  • Boston Children's Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
  • Brigham and Women's Hospital, Boston
A’ fastadhÌre 1/2
Aoisean 12 gu 49 · Gach gnè · Air ùrachadh 19 Gearr 2026 · NCT06709495

Bho ClinicalTrials.gov, dàta air a thogail 6 Dàmh 2026. Bidh gach sgrùdadh a’ suidheachadh a chuidi fhèin; bidh an sgioba sgrùdaidh a’ co-dhùnadh cò as urrainn pàirt a ghabhail.